Overall and cause-specific mortality in a cohort of home-/bisexual men, injecting drug users, and female partners of HIV-infected men

AIDS

Volumn 10, Issue 11, 1996, Pages 1257-1264

  Poole, W Kenneth ^a,j   Fulkerson, William ^a,b   Lou, Yu ^a   Kvale, Paul ^c   Hopewell, Philip C ^d   Hirschtick, Robert ^e   Glassroth, Jeffrey ^f   Rosen, Mark ^g   Mangura, Bonita ^h   Wallace, Jeanne ⁱ   Markowitz, Norman ^c  

^a RTI INTERNATIONAL   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c HENRY FORD HOSPITAL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^g BETH ISRAEL MEDICAL CENTER   (United States)

^h UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j NONE   (United States)

more..

Author keywords

AIDS; Cause specific mortality; HIV; HIV risk groups; Mortality; Survival analysis

Indexed keywords

ADULT; ARTICLE; BISEXUALITY; CAUSE OF DEATH; COHORT ANALYSIS; FEMALE; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONBIOLOGICAL MODEL; PRIORITY JOURNAL; UNITED STATES;

EID: 9544238138     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199609000-00012     Document Type: Article

References (36)

1. Centers for Disease Control and Prevention: Update: mortality attributable to HIV infection/AIDS among persons aged 25-44 years. United States, 1991 and 1992. MMWR 1993, 42:869-872.
2. National Center for Health Statistics: Annual Summary of Births, Marriages, Divorces, and Deaths: United States, 1993. Hyattsville: US Department of Health and Human Services, Public Health Service, CDC; 1994:18-20. [Monthly Vital Statistics Report, Vol 24, No 13].
3. National Center for Health Statistics: Annual Summary of Births, Marriages, Divorces, and Deaths: United States, 1993. Hyattsville: US Department of Health and Human Services, Public Health Service, CDC; 1994:18-20. [Monthly Vital Statistics Report, Vol 24, No 13].
4. Centers for Disease Control and Prevention: Update: acquired immunodeficiency syndrome. United States, 1994. MMWR 1995, 44:65-67.
5. Friedland G, Saltzman B, Vileno, J, Freeman K, Schrager L, Klein R: Survival differences in patients with AIDS. J Acquir Immune Defic Syndr 1991, 4:144-153.
6. Rothenberg R, Woolfel M, Stoneburner R, Milberg J, Parker R, Truman B: Survival with the acquired immunodeficiency syndrome. Experience with 5,833 cases in New York City. N Engl J Med 1987, 317:1297-1302.
7. Moore RD, Keruly J, Richman DD, Creagh-Kirk T, Chaisson RE: Natural history of advanced HIV disease in patients treated with zidovudine. AIDS 1992, 6:671-677.
8. Yarchoan R, Venzon D, Pluda J, et al.: CD4 count and the risk for death in patients infected with HIV receiving antiretroviral therapy. Ann Intern Med 1991, 115:184-189.
9. Pulmonary Complications of HIV Infection Study Group: Design of a prospective study of the pulmonary complications of human immunodeficiency virus infection. J Clin Epidemiol 1993, 46:497-507.
10. Cox DR, Oakes D: Analysis of Survival Data. London: Chapman and Hall; 1984.
11. SAS Institute, Inc.: SAS/STAT User's Guide, Version 6, 4th Edn, Vol 2. Cary: SAS Institute; 1990.
12. Cox DR: Regression models and life-tables (with discussion). J R Stat Soc [B] 1972, 34:187-220.
13. Kleinbaum DG, Kupper LL, Morgenstern H: Epidemiologic Research: Principles and Quantitative Methods. Belmont: Lifetime Learning Publications; 1982.
14. SAS Institute, Inc.: SAS Technical Report. SAS/STAT Software. The PHREG Procedure. Version 6. Cary: SAS Institute; 1991:217.
15. Melnick SL, Sherer R, Louis TA: Survival and disease progression according to gender of patients with HIV infection. JAMA 1994, 272:1915-1921.
16. Des Jarlais DC, Friedman SR, Marmor M, et al.: Development of AIDS, HIV seroconversion, and potential cofactors for T4 cell loss in acohort of intravenous drug users. AIDS 1987, 1:105-111.
17. Galli M, Lazzarin A, Saracco A, et al.: Clinical and immunological aspects of HIV infection in drug addicts. Clin Immunol Immunopathol 1989, 50:5166-5176.
18. Margolick J, Munoz A, Vlahov D, et al.: Changes in T-lymphocyte subsets in intravenous drug users with HIV-1 infection. JAMA 1992, 267:1631-1636.
19. Selwyn PA, Alcabes P, Hartel D, et al.: Clinical manifestations and disease progression in drug users with human immunodeficiency virus infection. N Engl J Med 1992, 327:1697-1703.
20. Carpenter C, Mayer K, Stein M, et al.: Human immunodeficiency virus infection in North American women: experiences with 200 cases and review of the literature. Medicine 1991, 70:307-325.
21. Hankins CA, Handley MA: HIV disease and AIDS in women: current knowledge and a research agenda. J Acquir Immune Defic Syndr 1992, 5:957-971.
22. Keenlyside R, Johnson A, Mabey D: The epidemiology of HIV-1 infection and AIDS in women. AIDS 1993, 7:583-590.
23. Benson C, Sha B, Urbanski P, Pottage J, Kessler H: Women with HIV disease: clinical progression and survival in a cohort followed at a University Medical Center. VIII International Conference on AIDS/III STD World Congress. Amsterdam, July 1992 [abstract MoC0034].
24. Brettle RP, Richardson AM, Burnson SM, et al.: Survival analysis by gender for HIV in Edinburgh. VIII International Conference on AIDS/III STD World Congress. Amsterdam, July 1992 [abstract MoC0066].
25. Chaisson RE, Keruly JC, Moore RD: Race, sex, drug use, and progression of human immunodeficiency virus disease. N Engl J Med 1995, 333:751-756.
26. Colford J, Ngo L, Tager I: Factors associated with survival in human immunodeficiency virus-infected patients with very low CD4 count. Am J Epidemiol 1994, 139:206-218.
27. Saah A, Hoover D, He Y, Kingsley L, Phair J: Factor influencing survival after AIDS: report from the Multicenter AIDS Cohort Study (MACS). J Acquir Immune Defic Syndr 1994, 7:287-295.
28. Wilkes MS, Felix JC, Fortin AH, Godwin TA, Thompson WG: Value of necropsy in acquired immunodeficiency syndrome. Lancet 1988, 2:85-88.
29. McKenzie R, Travis W, Dolan S, et al.: The causes of death in patients with human immunodeficiency virus infection: a clinical and pathologic study with emphasis on the role of pulmonary disease. Medicine 1991, 70:326-343.
30. Klatt EC: Diagnostic findings in patients with acquired immune deficiency syndrome (AIDS). J Acquir Immune Defic Syndr 1988, 1:459-465.
31. Moskowitz L, Hensley G, Chan JC, Adams K: Immediate causes of death in acquired immunodeficiency syndrome. Arch Pathol Lab Med 1985, 109:735-738.
32. Ambros R, Eun-Young L, Sharer L, Khan M, Robboy S: The acquired immunodeficiency syndrome in intravenous drug abusers and patients with a sexual risk: clinical and postmortem comparisons. Hum Pathol 1987, 18:1109-1114.
33. Wallace J, Hannah J: Pulmonary disease at autopsy in patients with the acquired immunodeficiency syndrome. West J Med 1988, 149:167-171.
34. Greenberg AE, Thomas PA, Landesman SH, et al.: The spectrum of HIV-1-related disease among outpatients in New York City. AIDS 1992, 6:849-859.
35. Wallace J, Rao V, Glassroth J, et al.: Respiratory illness in persons with human immunodeficiency virus infection. Am Rev Respir Dis 1993, 148:1523-1529.
36. Hirschtick R, Glassroth J, Jordan M, et al.: Bacterial pneumonia in persons infected with the human immunodeficiency virus. N Engl J Med 1995, 333: 845-851.